Hennion & Walsh Asset Management »

Silverback Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 176k 8.01

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Vanguard Index Fds Value Etf (VTV)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Blackrock Muniyield Quality Fund (MQY)
Proshares Tr S&p 500 High Etf (ISPY)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Janus Detroit Str Tr Hendersn Cap Etf (JSML)
Ishares Tr Invt Grad Sy Etf (IGEB)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Applied Materials (AMAT)
Alphabet Cap Stk Cl A (GOOGL)
Lam Research Corp Com New (LRCX)
Micron Technology (MU)
Nuveen Insd Dividend Advantage (NVG)

View all positions for Hennion & Walsh Asset Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Rubric Capital Management
Deerfield Management Company
Millennium Management
BlackRock
Standard Life Aberdeen
Sr One Capital Management
State Street Corporation
Franklin Resources
Tyro Capital Management
Vanguard Capital Management
UBS Group
Janney Montgomery Scott
Citadel Advisors

View all funds holding Silverback Therapeutics